Alex Goldberg

BlackBerry Limited (NASDAQ:BBRY) and Onconova Therapeutics, Inc. (NASDAQ:ONTX) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/19/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding BlackBerry Limited (NASDAQ:BBRY) and Onconova Therapeutics, Inc. (NASDAQ:ONTX).

BlackBerry Limited (NASDAQ:BBRY) a company that engages in the design, manufacture, and marketing of wireless solutions worldwide closed down in its previous session (-0.74%) on 9,196,520 shares traded as BlackBerry's BBM Chat Software to Come Preloaded on Some LG Phones. BlackBerry Limited (NASDAQ:BBRY) is currently down (-67.19%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about BlackBerry Limited (NASDAQ:BBRY)

Onconova Therapeutics, Inc. (NASDAQ:ONTX) a clinical-stage biopharmaceutical company that focuses on discovering and developing small molecule drug candidates to treat cancer closed down in its previous session (-18.68%) on 1,051,031 shares traded after Onconova Announced Results of Interim Analysis of Metastatic Pancreatic Cancer Study. Onconova Therapeutics, Inc. (NASDAQ:ONTX) is currently down (-58.98%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Onconova Therapeutics, Inc. (NASDAQ:ONTX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com